HNSBF - Hansa Biopharma GAAP EPS of -SEK4.79 revenue of SEK36.7M July, 20 2023 09:34 AM Hansa Biopharma AB 2023-07-20 09:34:17 ET Hansa Biopharma press release ( OTCPK:HNSBF ): Q2 GAAP EPS of -SEK4.79. Revenue of SEK36.7M (+24.0% Y/Y). For further details see: Hansa Biopharma GAAP EPS of -SEK4.79, revenue of SEK36.7M